Keith Carey with MaxGXL and MaxWLX

Keith Carey and His Business, Max International Products: MaxGXL and MaxWLX



Tuesday, August 19, 2008

Does MaxWLX Weight Loss Rip You Off?...

MaxWLX...

Developed at the University of Minnesota after seven years of scientific research, Max International has obtained worldwide distribution rights for this patented formula backed by hard-science, painstaking research and extensive clinical trials.

For More Information,

Please Contact:
Keith Carey - 818-510-4456

or

Take A Tour and Get Acquianted!!!

http://www.LivinToTheMAX.com

MaxWLX Weight Loss Program... 



8-week Clinical Trial Results in a 21.6 lb. Average Weight Loss!...

The double-blind, placebo controlled study conducted under physician supervision at the University of Connecticut revealed extraordinary results in just eight weeks.

The MaxWLX Group Lost:

21.5 lbs of Body Fat
3.96 Inches Off Their Waist
3.28 Inches Off Their Hips
1.20 Inches Off Each Thigh

The Trial Produced a 90.4% Greater Fat Loss in the MaxWLX Group... 

Two groups of women were placed on identical diet regimens and a supervised exercise program. One group received Max WXL and the other, a placebo.

Finally, a Science Patented Weight Loss Supplement That Successfully Targets Body Fat... 

Until now, there's been far too much failure when it comes to weight loss. Most people just can't stick with a faithful exercise program and restrictive diet. Two out of three American adults are now overweight. Billions are spent annually by well intentioned people who desperately want to lose the weight. It's an endless Yo-Yo cycle.

The MaxWLX Trial Reduced Leptin Levels 42% on Average... 

Because it takes at least 3-4 weeks for Leptin levels to decrease to lower levels, it is recommended that you remain on the product for at least 12 weeks to experience significant weight loss. User groups have remained on the product long after that point in order to continue losing weight and maintaining lower Leptin levels, thus reducing cravings and appetites.













No comments: